Connect with us

Technology

Patients as Partners® Europe Announces the Launch of 8th Annual Meeting with 2024 Keynotes and Topics

Published

on

Patients as Partners® Europe announces its dates, keynotes and topics for the London meeting which is attended by pharma and biotech R&D, patient advocacy, and technologists to include and empower the patient voice for greater efficiencies in medicine development.

NEW YORK, March 7, 2024 /PRNewswire-PRWeb/ — The Conference Forum today announced the launch of the 8th annual Patients as Partners® Europe meeting, taking place May 14-15, 2024, at Plaisterers’ Hall, in London, England. Patients as Partners® Europe offers an unparalleled opportunity to hear from pharma R&D and patient advocacy on how patient involvement gets done to drive greater efficiencies and inclusivity in clinical research with better outcomes.

“Patients as Partners® Europe presents case examples on how patient involvement in clinical research can accelerate medicine development, how it can improve better access, inclusivity and diversity,” said Valerie Bowling, Executive Director

“Patients as Partners Europe brings advocates and sponsors together in a unique forum focused on improving collaborations that result in meaningful impact for patients,” said 2024 co-chair, Victoria DiBiaso, MPH, Global Head, Patient Informed Development & Health Value Translation, Sanofi.

The 2024 keynotes and featured speakers include:

Patient Advocate Keynote Derek Stewart, OBE on understanding mental health support in clinical researchPatient Advocate Keynote Sarah Zenner Dolan, a former biotech executive on navigating clinical trials as a patientGSK’s Andrew Garvey, Global Patient Advocacy Lead, on what has been working, and what has not, in GSK’s effort to advance patient engagement in clinical trialsPfizer’s Patrick Gallogly, Medical Advisor, Pfizer, on the learnings generated from an industry-first LGBTQ+ oncology advisory boardLundbeck’s Anders Lassen, Senior Director, Patient Insights, on using patient-centric integrated evidence approaches to inform drug development decisionsBoehringer Ingelheim’s Annie Gilbert, Global Patient Advocacy Lead, on the pilot program bridging the communication gap by sending trial updates to patientsIpsen’s Oleksandr Gorbenko, Global Patient Affairs Director, Neurosciences, on how Ipsen partnered with patient advocacy to create robust patient experience mappingAstraZeneca’s Lisa Kerr, Senior Director, R&D Patient Science, on creating a measurement strategy and business investment case to scale patient-centric R&D approachesAstellas’ Stephen Head, Senior Director, Patient Partnerships, on instilling conscious awareness of the patient into everyday work practicesProstate Cancer Research’s David James, Director of Patient Projects, on demystifying and diversifying clinical trials to engage underserved communities

“Patients as Partners® Europe presents case examples on how patient involvement in clinical research can accelerate medicine development, how it can improve better access, inclusivity and diversity,” said Valerie Bowling, Executive Director

Key topics to be addressed include:

The future of patient-informed researchUnderstanding patient preferences in decentralized clinical trialsAdvancing health equity and diversifying clinical trials to engage underserved communitiesThe patient experience data landscape and returning patient dataTurning patient insights into actionMapping and measuring patient engagementPatient burden-reducing solutions and technologiesRegulatory requirements and patient engagement in drug development

The 2024 meeting is co-chaired by Sanofi’s Victoria DiBiaso, MPH, Global Head, Patient Informed Development & Health Value Translation; Patient Advocate, Alfred Samuels; and Parexel’s Rosamund Round, VP, Patient Engagement.

About Patients as Partners® Europe:
Patients as Partners® Europe is co-produced with patients, industry, academia, government and nonprofit organizations to establish a well-rounded program that addresses the needs of all stakeholders seeking to implement and advance patient involvement, access and diversity across the entire clinical development continuum. To learn more about Patients as Partners and access the full agenda, visit PatientsAsPartnersEU.com.

About the Conference Forum:
The Conference Forum is a life science industry research, conference development and marketing firm. The company brings the full spectrum of executives together to share ideas and information on how to advance efficient medicine development and delivery, patient diversity and access. They produce trusted conferences, webinars, podcasts, digital editorial and provide marketing services. To learn more, visit theconferenceforum.org.

Media Contact

Bre Bugbee, Patients as Partners®, (646) 290-8449, service@tcfllc.org, https://patientsaspartnerseu.com/ 

View original content:https://www.prweb.com/releases/patients-as-partners-europe-announces-the-launch-of-8th-annual-meeting-with-2024-keynotes-and-topics-302082357.html

SOURCE Patients as Partners®

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Bloomberg Accelerates Financial Analysis with Gen AI Document Insights

Published

on

By

Research Analysts & Corporate Decision Makers Can Ask Complex Questions within Company Documents

NEW YORK, April 7, 2025 /PRNewswire/ — Bloomberg today announced the launch of AI-Powered Document Insights which uses generative AI to make it easier for research analysts and corporate decision makers to quickly surface insights from a company document by asking questions in everyday conversational language. This innovative research solution is an evolution of Bloomberg’s AI-Powered Earnings Call Summaries, complements AI-Powered News Summaries, and links seamlessly with Bloomberg’s other purpose-built analytical tools and workflows as part of the company’s mission to reimagine the Bloomberg Terminal for the age of AI.

AI-Powered Document Insights provides users with robust search and summarization capabilities made possible by Bloomberg’s decades of expertise and more than 15 years of leadership in applying AI in the financial domain. Bloomberg Intelligence analysts helped train the generative AI models so they more accurately understand the nuances of financial language by using Bloomberg’s AI guardrail systems. The research solution enables customers to adjust their positions and investment views on a company by quickly analyzing text and structured data within a company document from a vast library of trusted and premium content. This research library on the Bloomberg Terminal includes more than 200 million company documents, more than 5,000 Bloomberg News stories published each day on the markets, economies, industries, and companies that matter, as well as research content like Bloomberg Intelligence reports which cover thousands of companies.

Magdalena Richardson, Credit Trading Strategist at NatWest Markets Plc, said: “What I like about AI-Powered Document Insights is that it provides a great summary of a company’s comments when asked a direct question. For example, within an earnings call transcript for an original equipment manufacturer, the solution can be asked about the impact of tariffs. I think this solution is a godsend on a day when you have multiple earnings calls and cannot attend them all or need to revisit a topic.”

Thymen Rundberg, Equity Research Associate at ING, said: “What I find valuable is that AI-Powered Document Insights allows me to quickly find specific information within earnings call transcripts, saving me time versus manually searching through the document. The tool also allows me to stay up to date with more peers of companies in my coverage. This was definitely a more tedious task before.”

Bloomberg will continue to use generative AI to enhance research solutions like AI-Powered Document Insights with additional document coverage, product features and integrations to help customers discover more answers and actionable insights with a user experience that is easy and comprehensive. Click here to request to join the beta program for our future research solutions enhanced by generative AI. 

Starting today, customers can explore the new interface and its features like ‘Ask a Question’, where users can either explore their hypothesis about developing investment themes like “tariffs” or retrieve specific information like “procurement costs.” The feature covers company documents and transcripts for earnings calls, conference presentations, investor days, capital markets days, shareholder meetings, M&A calls, sales results calls, guidance calls, and more. The solution also incorporates transparency links to highlight relevant excerpts in the original document and audio replays to hear the tone and tenor of executives and corporate spokespeople. ‘Key Notes’ provides a structured overview of Bloomberg selected topics raised in company presentations.

Suzanne Szur, Research and Companies Product Manager at Bloomberg, said: “With AI-Powered Document Insights, we’re delivering our customers a solution that is infused with financial domain knowledge. It’s been developed in close collaboration with our customers and evaluated by our team of product, data and technology experts who understand the importance of responsible AI down to the design features. Very soon we’ll launch additional research solutions to help financial professionals and their teams find unique insights, improve their research methods, and develop investment strategies tailored to various time horizons in this uncertain macro environment.”

Bloomberg’s research solutions help transform the investment research and analysis process so clients can add actionable resources to their data and tech stacks for single-desktop and enterprise-wide use. Clients can optimize their research offering so that trusted and consistent data is deeply integrated into research and production workflows throughout their enterprise, and their unique views are quickly distributed to counterparties. Bloomberg’s research solutions provide organizations access to consistent, high-quality data and analytics from Bloomberg as well as hundreds of valued content partners.

For teams of quants, research analysts and data scientists, Investment Research Data products offer end-to-end solutions to power workflows across the enterprise. This enables firms to test their investment hypotheses rigorously with granular data across asset classes and deep point-in-time history. The datasets are seamlessly interconnected with other content, including alternative data for both public and private companies, and available via a number of flexible delivery mechanisms, including the cloud. Bloomberg’s Research Management Solutions (RMS) Platform is also designed to optimize the research process by driving front-office efficiency, facilitating collaboration around ideas and throughout the investment lifecycle. Bloomberg’s RMS is also interoperable with Bloomberg’s other enterprise products, including portfolio and risk analytics offerings and leading order and investment management technology solutions, for a more comprehensive, end-to-end workflow.

About AI at Bloomberg
Since 2009, Bloomberg has been building and using artificial intelligence (AI) in the finance domain – including machine learning (ML), natural language processing (NLP), information retrieval (IR), time-series analysis, and generative models – to help process and organize the ever-increasing volume of structured and unstructured financial information. With this technology, Bloomberg is developing new ways for financial professionals and business leaders to derive valuable intelligence and actionable insights from high-quality financial information and make more informed business decisions.

About the Bloomberg Terminal
For more than four decades, the Bloomberg Terminal has revolutionized the financial services industry by bringing transparency and innovation to the capital markets. Trusted by the world’s most influential decision-makers, the Terminal provides real-time access to news, data, insights and trading tools that help our customers turn knowledge into action.

About Bloomberg
Bloomberg is a global leader in business and financial information, delivering trusted data, news, and insights that bring transparency, efficiency, and fairness to markets. The company helps connect influential communities across the global financial ecosystem via reliable technology solutions that enable our customers to make more informed decisions and foster better collaboration. For more information, visit Bloomberg.com/company or request a demo.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bloomberg-accelerates-financial-analysis-with-gen-ai-document-insights-302421875.html

SOURCE Bloomberg L.P.

Continue Reading

Technology

ZERO INDUSTRIAL ANNOUNCES $10 MILLION SERIES A INVESTMENT TO ACCELERATE DEVELOPMENT OF THERMAL ENERGY STORAGE IN NORTH AMERICA

Published

on

By

CHARLESTON, S.C., April 7, 2025 /PRNewswire/ — Zero Industrial, Inc. (“Zero Industrial”), a leading development company decarbonizing industrial heat by utilizing thermal energy storage (“TES”) systems, announced today that it successfully closed $10 million in funding led by Evok Innovations (“Evok”) with participation from Rusheen Capital Management (“Rusheen”).

“We are excited to partner with Evok and Rusheen to help us accelerate the deployment of thermal energy storage projects in North America,” said Ted Kniesche, founder and CEO. “We are rapidly originating project opportunities with industrial customers who want to reduce their energy costs and lower their carbon footprint by using stored electricity as thermal energy, instead of burning gas, fuel oil or coal.”

Zero Industrial was founded in 2024 by Ted Kniesche and Jim McDermott to decarbonize industrial heat using commercially-available TES systems at industrial facilities. The company provides full project development services to its customers, including technology selection, project design and engineering of each TES system. Importantly, Zero Industrial will fully finance each project and sell clean heat or steam to its customers under a long-term Heat-as-a-Service contract without any upfront capital outlay required by the industrial facility. 

“We are excited to partner with Ted and his team at Zero Industrial to build a market leading development business that will accelerate the decarbonization of industry – one of the hardest to abate sectors of our economy,” said Naynika Chaubey, Partner at Evok Innovations. “We continue to see massive growth from cheap, intermittent renewable generation, coupled with increasingly impacted electrical grids. Zero Industrial capitalizes on these market challenges by deploying thermal storage projects that will shift curtailed or off-peak clean electricity to baseload heat and steam used by industries globally.”

Zero Industrial is actively originating and developing projects in the United States and Canada and seeking industrial customers looking to decarbonize their industrial heat, eliminate criteria pollutants and reduce energy costs and volatility.

About Zero Industrial, Inc.

Zero Industrial is a leading developer of industrial decarbonization projects, utilizing thermal energy storage technologies to eliminate the combustion of fossil fuels for heat and steam production at industrial facilities. Zero Industrial offers its customers a full end-to-end development solution from design and engineering to project execution and delivery. Heat generated from its projects will be sold under a Heat-as-a-Service agreement without requiring any capital investment from its customers. Zero Industrial is actively originating and developing projects in the United States and Canada and exploring additional international markets. For more information, please visit www.zeroindustrial.energy

About Evok Innovations

Evok is a clean tech venture capital fund focused on supporting exceptional entrepreneurs with bold visions for scaling novel technologies within heavy industry. At Evok, we provide value beyond capital by leveraging our team of technologists and company builders, along with our limited partner group—which includes major financial institutions and industrial leaders—to help accelerate the success of our companies.

In 2016, Evok was founded with the thesis of collaborating with industrial partners to invest in and scale novel technologies in the energy sector. With the launch of Evok Fund II in 2022, we expanded this mandate, bringing in strategic partners across new industrial verticals, including critical minerals. Evok is actively investing out of Fund II, a $284M USD fund focused on supporting Series A+ companies in North America that are taking novel approaches to supporting the energy transition across a wide array of sectors and industries. For more information, please visit: www.evokinnovations.com

About Rusheen Capital Management

Rusheen Capital Management (“RCM”) is a Santa Monica-based private equity firm specializing in investments that promote sustainability and resource efficiency across the energy transition landscape. Founded in 2015, RCM focuses on growth-stage companies in sectors such as carbon capture and utilization, energy transition, low-carbon energy, and water sustainability. Since 2003, RCM’s principals founded, ran, and invested in over 40 energy transition companies across the entire industrial economy. For more information, please visit www.rusheen.com.

For more information, contact Sara Holba at info@zeroindustrial.energy

View original content to download multimedia:https://www.prnewswire.com/news-releases/zero-industrial-announces-10-million-series-a-investment-to-accelerate-development-of-thermal-energy-storage-in-north-america-302421563.html

SOURCE Zero Industrial, Inc.

Continue Reading

Technology

MakeWell Announces Free Access to AI-Driven Healthcare Companion App in Recognition of the WHO’s World Health Day

Published

on

By

SAVANNAH, Ga., April 7, 2025 /PRNewswire/ — In honor of the annual World Health Day, MakeWell, a pioneering AI healthcare start-up, is proud to announce that its AI-driven healthcare companion app is now available free of charge on the App Store and Google Play. This initiative aligns with MakeWell’s commitment to expanding access to critical healthcare information and resources, particularly for underserved populations worldwide.

In keeping with this year’s theme, “Healthy Beginnings, Hopeful Futures” MakeWell notes that approximately 300,000 women lose their lives during pregnancy or childbirth each year. The vast majority of these deaths occur in low resource settings due to preventable causes. MakeWell’s AI-powered app is designed to bridge healthcare gaps by providing real-time, personalized guidance on maternal health, chronic disease management, and general well-being. The MakeWell app supports 200+ languages, broadening its worldwide appeal.

“With the launch of our free app, we are taking a step toward making healthcare more accessible to everyone, regardless of geography or economic status,” said Daniel Carroll, Founder of MakeWell. “No one should lose their life due to a lack of medical knowledge or access to care. Our AI-driven platform empowers individuals, putting reliable, evidence-based health insights right at their fingertips.”

MakeWell’s app offers features such as symptom assessments, possible treatment/care options, preventative health recommendations, and connections to local healthcare resources. By leveraging advanced AI technology, it serves as a 24/7 digital health companion, supporting individuals in making informed medical decisions. The MakeWell app supports 200+ languages, broadening its worldwide appeal.

The MakeWell app is now available for free download in the App Store. To learn more about how MakeWell is working to create a healthier world, please visit us at www.makewell.ai 

View original content to download multimedia:https://www.prnewswire.com/news-releases/makewell-announces-free-access-to-ai-driven-healthcare-companion-app-in-recognition-of-the-whos-world-health-day-302418860.html

SOURCE MakeWell

Continue Reading

Trending